{"id":958037,"date":"2026-05-05T07:07:20","date_gmt":"2026-05-05T11:07:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/"},"modified":"2026-05-05T07:07:20","modified_gmt":"2026-05-05T11:07:20","slug":"autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/","title":{"rendered":"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LONDON and GAITHERSBURG, Md., May  05, 2026  (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc (Nasdaq: AUTL), a commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced that the Company will release its first quarter 2026 financial results and operational highlights before open of U.S. markets on Thursday, May 14, 2026.<\/p>\n<p align=\"justify\">Management will host a conference call and webcast at\u00a08:30am EDT \/ 1:30pm BST to discuss the company\u2019s financial results and provide a general business update. Conference call participants should pre-register using <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=soUuMmWH9SwUEb9FkwrOV9-ZT2s0AHKFW6NT0jKecftfq9dKxaKay-1s-EIPD0obM1box_qYbf7I38HgKSq3WNFsDv_ioTTb5n48rMtftlgHuYb0bv3OhlHt7XprAGEh334Ep5Nu9uGSyvBNgDrb_CC2HcD7LpaSYLFBJYks2-c=\" rel=\"nofollow\" target=\"_blank\">this link<\/a> to receive the dial-in numbers and a personal PIN, which are required to access the conference call.<\/p>\n<p align=\"justify\">A simultaneous audio webcast and replay will be accessible on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xPgOyWI6ZYdOL5LcC9a8IPa0-mxyHjXE5SVb0LfIVQxwqrR5zbL2AZ0volPYkU4zViZCUFKKdJ0BbKcfJ1-YXtKQ5e78-uZZApLxAYVu-kKMxNzUgXHDoW-Fc_5zMc2N2h3cCBeP7WeLFz4K2nPvyA==\" rel=\"nofollow\" target=\"_blank\">events section<\/a> of Autolus\u2019 website.<\/p>\n<p align=\"justify\">\n        <strong>About Autolus Therapeutics plc<\/strong><br \/>\n        <br \/>Autolus Therapeutics plc\u00a0(Nasdaq: AUTL) is a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation T cell therapies and candidates for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, Autolus is engineering precisely targeted and controlled T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate these cells. Autolus has a marketed therapy, AUCATZYL<sup>\u00ae<\/sup>, and a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ddH0ZtpHW7ERNW_QEEVa1oIys7Imo8ESvZaw4BhmJYciuUAv4a4G34FsxAzVUNegqeglwDIg9arwC6xWVuQY1ZDXy8AiGvbT8rySmxcC5yt6cXeZ_3BJQSJ93-TZXSeVeaCIktU7QaUWpPRMhdznD09BS2PCeRUPbnDxOlJqeCr8Azqcn0IjFW7o2rcCGHapH7RCuGLbuu4VkovqhjJhsn-jjFNw8fr4sdvM2B1cQMv1goNK7owXX0naRrmQH6BfwI7tyldyKpZw6oK9lF7_Aw==\" rel=\"nofollow\" target=\"_blank\">www.autolus.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contact:\u00a0<\/strong>\u00a0<\/p>\n<p align=\"justify\">Amanda Cray\u00a0<br \/>+1 617-967-0207\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OaNWKvXlKrlER9OLPiYtkOSSNACmu_gQiEk5gP7-BOPgXvDwRt6g5Y_1bq-6sjeyl7AytsHpd0DrAmYuK6kiYZ7kpph3sndonswmts0iRLg=\" rel=\"nofollow\" target=\"_blank\">a.cray@autolus.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDJkZjY2YTctMzIwOC00NTc5LThjZjItMmM1ZThiZGY4NzMyLTExMTEyMDEtMjAyNi0wNS0wNS1lbg==\/tiny\/Autolus-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON and GAITHERSBURG, Md., May 05, 2026 (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc (Nasdaq: AUTL), a commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced that the Company will release its first quarter 2026 financial results and operational highlights before open of U.S. markets on Thursday, May 14, 2026. Management will host a conference call and webcast at\u00a08:30am EDT \/ 1:30pm BST to discuss the company\u2019s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. A simultaneous audio webcast and replay will be accessible on the events section of Autolus\u2019 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-958037","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON and GAITHERSBURG, Md., May 05, 2026 (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc (Nasdaq: AUTL), a commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced that the Company will release its first quarter 2026 financial results and operational highlights before open of U.S. markets on Thursday, May 14, 2026. Management will host a conference call and webcast at\u00a08:30am EDT \/ 1:30pm BST to discuss the company\u2019s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. A simultaneous audio webcast and replay will be accessible on the events section of Autolus\u2019 &hellip; Continue reading &quot;Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-05T11:07:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026\",\"datePublished\":\"2026-05-05T11:07:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/\"},\"wordCount\":245,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/\",\"name\":\"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=\",\"datePublished\":\"2026-05-05T11:07:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/","og_locale":"en_US","og_type":"article","og_title":"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026 - Market Newsdesk","og_description":"LONDON and GAITHERSBURG, Md., May 05, 2026 (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc (Nasdaq: AUTL), a commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced that the Company will release its first quarter 2026 financial results and operational highlights before open of U.S. markets on Thursday, May 14, 2026. Management will host a conference call and webcast at\u00a08:30am EDT \/ 1:30pm BST to discuss the company\u2019s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. A simultaneous audio webcast and replay will be accessible on the events section of Autolus\u2019 &hellip; Continue reading \"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-05T11:07:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026","datePublished":"2026-05-05T11:07:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/"},"wordCount":245,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/","name":"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=","datePublished":"2026-05-05T11:07:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjczMiM3NTgxODUwIzIwOTk2MzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-14-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=958037"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958037\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=958037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=958037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=958037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}